In
cartilage regeneration, stem cells have the potential for multiple
differentiation and self-replication, making it an ideal choice for
use as seed cells. Growing regenerative medicine industry and
increasing demand for stem cells in the development of various types
of cell therapies are expected to drive growth of the market over the
forecast period. Mesenchymal stem cells are the most widely applied
stem cells in the field of cartilage regeneration.
Request
Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/2448
Market
Dynamics
Growing
osteoarthritis incidence among the global population is supporting
the adoption of stem cell cartilage regeneration therapy. For
instance, according to November 2017, Arthritis Foundation data
findings, with the increase in global geriatric population,
degenerative disease disorders such as osteoarthritis will impact at
least 130 million individuals around the globe by 2050.
Furthermore,
various government agencies are focusing on policies to enhance
adoption of stem cell therapies, which is expected to drive growth of
stem cell cartilage regeneration market in the near future. For
instance, in December 2016, the 21st Century Cures Act (Cures Act)
was signed into law by the U.S. FDA, thereby allowing legislation for
an expedited approval path for cellular medicines designated as
regenerative medicine advanced therapies (RMATs) to patients who are
in need of it.
Stem
Cell Cartilage Regeneration Market - Regional Insights
On
the basis of region, the global stem cell cartilage regeneration
market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America is expected to be the
most conducive region for growth of the stem cell cartilage
regeneration market over the forecast period, due to high presence of
key players in the region. Key players such as Vericel Corporation,
Osiris Therapeutics, among others are focusing on various growth
strategies such as gaining regulatory product approvals and launching
innovative stem cell based cartilage regeneration products and
technologies in the market.
Stem
Cell Cartilage Regeneration Market - Competitive Landscape
Key
players operating in the global stem cell cartilage regeneration
market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd.,
Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc.,
BioTissue SA, and Vericel Corporation.
Detailed
Segmentation:
Global
Stem Cell Cartilage Regeneration Market, By Stem Cell Type:
-
Hematopoietic Stem Cells (HSCs)
-
Pluripotent Stem Cells (iPSC/ESCs)
-
Mesenchymal Stem Cells (MSCs)
Global
Stem Cell Cartilage Regeneration Market, By Treatment:
-
Microfracture
-
Osteochondral Transplant
-
Autologous Chondrocyte Implantation
-
Stem Cell Injections
For
More Information, Browse Complete Report Here:
https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment